Literature DB >> 1812215

Cytotoxicities of some flavonoid analogues.

M Cushman1, D Nagarathnam.   

Abstract

An array of 55 flavones having a variety of substituents was evaluated for cytotoxicity in five cancer cell cultures: A-549 lung carcinoma, MCF-7 breast carcinoma, HT-29 colon adenocarcinoma, SKMEL-5 melanoma, and MLM melanoma. Fifteen of the 55 flavone derivatives were significantly active against at least one of these cell cultures, and 4'-[(t-butyldi-methylsily)oxy]-7,8-dihydroxy-3',5'- dimethoxyflavone [40] was the most active of all. Structure-activity relationships of these compounds are discussed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1812215     DOI: 10.1021/np50078a027

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  5 in total

Review 1.  Discovering natural product modulators to overcome multidrug resistance in cancer chemotherapy.

Authors:  Chung-Pu Wu; Shinobu Ohnuma; Suresh V Ambudkar
Journal:  Curr Pharm Biotechnol       Date:  2011-04       Impact factor: 2.837

2.  Inhibitory effect of flavonoids on mutant H-Rasp protein.

Authors:  Tariq A Masoodi; Adel H Alhamdanz
Journal:  Bioinformation       Date:  2010-06-15

3.  Iminoflavones combat 1,2-dimethyl hydrazine-induced aberrant crypt foci development in colon cancer.

Authors:  V Ganga Prasad; Shishir Kawade; B S Jayashree; Neetinkumar D Reddy; Albi Francis; Pawan G Nayak; Anoop Kishore; K Nandakumar; C Mallikarjuna Rao; Rekha R Shenoy
Journal:  Biomed Res Int       Date:  2014-06-05       Impact factor: 3.411

4.  Structural antitumoral activity relationships of synthetic chalcones.

Authors:  Cesar Echeverria; Juan Francisco Santibañez; Oscar Donoso-Tauda; Carlos A Escobar; Rodrigo Ramirez-Tagle
Journal:  Int J Mol Sci       Date:  2009-01-09       Impact factor: 6.208

5.  Estrogen receptor α and aryl hydrocarbon receptor independent growth inhibitory effects of aminoflavone in breast cancer cells.

Authors:  Ashley M Brinkman; Jiacai Wu; Karen Ersland; Wei Xu
Journal:  BMC Cancer       Date:  2014-05-20       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.